Skip to main content

Table 5 Multivariate analysis

From: Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapy

 

Overall survival

 

HR

95% CI

p

Age

1.412

1.016 - 1.961

0.040

Previous operation

1.641

1.145 - 2.351

0.007

NLR

2.245

2.092 - 3.633

0.004

PLR

1.743

1.142 - 2.847

0.020

cNLR

2.468

1.567 - 3.886

< 0.001

cPLR

1.473

1.038 - 2.090

0.030

  1. NLR Neutrophil lymphocyte ratio, PLR Platelet lymphocyte ratio, cNLR Change of neutrophil lymphocyte ratio after 1 cycle of chemotherapy, cPLR Change of platelet lymphocyte ratio after 1 cycle of chemotherapy.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us